• Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues


Bayer to Establish Innovation Center in California Bay Area

San Francisco Mayor Gavin Newsom, Bayer HealthCare head of global drug discovery Andreas Busch, and Bayer vice president of biologics research Terry Hermiston, will announce this morning the establishment of Bayer's U.S. Innovation Center in Mission Bay, California. The 50,000-square-foot facility will house the company's hematology research program, as well as research on cardiology, oncology, women's health, and diagnostic imaging, according to the San Francisco Business Times.

The center strengthens the Bay Area's existing biotech cluster. The companies Merck, Celgene, Nektar Therapeutics, and FibroGen, and several smaller biotech companies also have facilities there. The area is also home to the University of California at San Francisco's J. David Gladstone Institutes. Bayer's new space will be located across the street from the university.

Bayer currently employs 1,300 people in Berkeley. The company's expansion is one of the largest capital investments Bayer has undertaken. It should be completed by 2013.

Exclusive Research